Tofacitinib in the Treatment of Ulcerative Colitis

Speciality: Gastroenterology

Description:

A warm welcome to all the medical professionals in this interesting session of Tofacitinib in the treatment of Ulcerative Colitis.. We have Prof. Anand N. Malaviya, Dr Indrajit Agrawal, and Dr Sanjiv Kapoor to lead the session.

Ulcerative colitis treatment usually involves either medication therapy or surgery. Different categories of medications can help in treating ulcerative colitis.

Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases, which eventually helps in controlling different inflammatory diseases. 

Oral formulation of tofacitinib has been approved for the treatment of patients with moderate–severe ulcerative colitis as Tofacitinib and other JAK inhibitors address an unmet need in the armamentarium of IBD therapy. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars